PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunology and Transfusion Medicine, Department of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.\', \'Department of Medicine II, University Hospital Munich, and German Centre for Infection Research (DZIF) (partner site Munich), Munich, Germany.\', \'Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler Institut, Greifswald, Germany.\', \'Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, ON, Canada.\', \'Max von Pettenkofer Institute, Virology, Ludwig Maximilians University of Munich, and DZIF, Munich, Germany.\', \'Department of Medicine III, University Hospital Munich, Munich, Germany.\', \'Heart Center Freiburg University, Cardiology and Angiology I and Medical Intensive Care, Medical Center.\', \'Institute of Experimental and Clinical Pharmacology and Toxicology, and.\', \'Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.\', \'Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.\', \'Department of Anesthesiology and Intensive Care Medicine, and.\', \'Department of Neurology, University Medicine Greifswald, Greifswald, Germany.\', \'Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy; and.\', \'Institute of Pharmacology Biology, Biocenter, Goethe University, Frankfurt am Main, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/blood.2021012938
?:doi
?:hasPublicationType
?:journal
  • Blood
is ?:pmid of
?:pmid
?:pmid
  • 34280256
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.434
?:rankingScore_hIndex
  • 410
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all